Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma

Archives of Ophthalmology

Volumn 130, Issue 10, 2012, Pages 1268-1271

  Ghassemi, Fariba ^a   Shields, Carol L ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CATARACT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOTHERAPY; DISEASE CONTROL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ENUCLEATION; EYE DISEASE; FOLLOW UP; HUMAN; INTRAOCULAR HYPOTENSION; LONG TERM CARE; MULTIPLE CYCLE TREATMENT; PHTHISIS BULBI; PIGMENT EPITHELIUM; PRERETINA HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA HEMORRHAGE; RETINA VASCULITIS; RETINOBLASTOMA; SCHOOL CHILD; SIDE EFFECT; SUBRETINA HEMORRHAGE; VITREOUS DISEASE; VITREOUS HEMORRHAGE; VITREOUS SEEDING;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; INTRAVITREAL INJECTIONS; MELPHALAN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; RADIOTHERAPY, ADJUVANT; RETINAL NEOPLASMS; RETINOBLASTOMA; TREATMENT OUTCOME; VITREOUS BODY;

EID: 84867346156     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.1983     Document Type: Article

References (11)

1. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276-2280. (Pubitemid 44838917)
2. Shields CL, Ramasubramanian A, Thangappan A, et al. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone vs chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology. 2009;116(3):544.e1-551.e1.
3. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129(11):1399-1406.
4. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114(11):1339-1343. (Pubitemid 26398719)
5. Ericson LA, Rosengren BH. Present therapeutic resources in retinoblastoma. Acta Ophthalmol (Copenh). 1961;39:569-576.
6. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol. 2003;33(12):601-607. (Pubitemid 43102812)
7. Kivelä T, Eskelin S, Paloheimo M. Intravitreal methotrexate for retinoblastoma. Ophthalmology. 2011;118(8):1689-1689.e6.
8. Ericson LA, Karlberg B, Rosengren BH. Trials of intravitreal injections of chemotherapeutic agents in rabbits. Acta Ophthalmol (Copenh). 1964;42(4):721-726.
9. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res. 1987;78(8):858-868. (Pubitemid 17124771)
10. Kanecko A. How to perform vitreous injection ofmelphalan to treat recurrent vitreous seeding of retinoblastoma. http://members3.jcom.home.ne.jp/ akiakikaneko/image/616312Poster200&100V-PVI-070216.pdf. Accessed July 13, 2012.
11. Munier FL. Intravitreal chemotherapy with melphalan for vitreous disease in advanced retinoblastoma: evidence for safety and efficacy. Paper presented at: Biennial International Society of Ocular Oncology; November 16, 2011; Buenos Aires, Argentina.